Debomoy K. Lahiri

School of Medicine, Psychiatry

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Debomoy K. Lahiri

• School of Medicine
  School of Medicine
  
  Psychiatry
  
  

  Current Appointments:

  Professor of Neurobiology

  
  
  

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  D.K. Lahiri; B. Ray

  Abnormal cerebrospinal fluid (CSF) dynamics in Alzheimer's disease and normal pressure hydrocephalus: CSF-amyloid β precursor protein metabolites as possible biomarkers

  European Journal of Neurology. 2013;20(2):211-213.
  0

• 2.

  2013

  Debomoy K. Lahiri; Bryan Maloney; Jack T. Rogers; Yuan-Wen Ge

  PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE)

  BMC Genomics. 2013;14(1).
  0

• 3.

  2013

  Craig A. Erickson; Logan K. Wink; Balmiki Ray; Maureen C. Early; Elizabeth Stiegelmeyer; Lauren Mathieu-Frasier; Vanessa Patrick; Debomoy K. Lahiri; Christopher J. McDougle

  Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome

  Psychopharmacology. 2013:1-10.
  0

• 4.

  2013

  Zheng-Ming Ding; Zachary A. Rodd; Eric A. Engleman; Jason A. Bailey; Debomoy K. Lahiri; William J. McBride

  Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats

  Addiction Biology. 2013;18(2):297-306.
  0

• 5.

  2012

  Justin M. Long; Debomoy K. Lahiri

  Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders

  Experimental Neurology. 2012;235(2):402-418.
  5

• 6.

  2012

  Bryan Maloney; Debomoy K. Lahiri

  Structural and functional characterization of H2 haplotype MAPT promoter: Unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease

  Gene. 2012;501(1):63-78.
  2

• 7.

  2012

  Bryan Maloney; Kumar Sambamurti; Nasser Zawia; Debomoy K. Lahiri

  Applying epigenetics to alzheimer's disease via the latent early-life associated regulation (LEARn) model

  Current Alzheimer Research. 2012;9(5):589-599.
  1

• 8.

  2012

  N.H. Zawia; D.K. Lahiri

  Epigenetics: A paradigm shift in Understanding Alzheimer's Disease

  Current Alzheimer Research. 2012;9(5):525-526.
  1

• 9.

  2012

  Syed Waseem Bihaqi; Axel Schumacher; Bryan Maloney; Debomoy K. Lahiri; Nasser H. Zawia

  Do epigenetic pathways initiate late onset alzheimer disease (LOAD): Towards a new paradigm

  Current Alzheimer Research. 2012;9(5):574-588.
  2

• 10.

  2012

  David Tweedie; Ryan A. Ferguson; Kelly Fishman; Kathryn A. Frankola; Henriette Van Praag; Harold W. Holloway; Weiming Luo; Yazhou Li; Luca Caracciolo; Isabella Russo; et al.

  Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease

  Journal of Neuroinflammation. 2012;9.
  7

• 11.

  2012

  Debomoy K. Lahiri; Bryan Maloney

  The "lEARn" (latent early-life associated regulation) model: An epigenetic pathway linking metabolic and cognitive disorders

  Journal of Alzheimer's Disease. 2012;30(SUPPL.2):S15-S30.
  2

• 12.

  2012

  Yazhou Li; Srinivasulu Chigurupati; Harold W. Holloway; Mohamed Mughal; David Tweedie; Daniel A. Bruestle; Mark P. Mattson; Yun Wang; Brandon K. Harvey; Balmiki Ray; et al.

  Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis

  PLoS ONE. 2012;7(2).
  9

• 13.

  2012

  David Olivares; Varun K. Deshpande; Ying Shi; Debomoy K. Lahiri; Nigel H. Greig; Jack T. Rogers; Xudong Huang

  N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for alzheimer's disease, vascular dementia and parkinson's disease

  Current Alzheimer Research. 2012;9(6):746-758.
  5

• 14.

  2012

  Jason A. Bailey; Debomoy K. Lahiri

  Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: Differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls

  Journal of Neurochemistry. 2012;122(4):672-680.
  0

• 15.

  2012

  Balmiki Ray; Jason A. Bailey; Jay R. Simon; Debomoy K. Lahiri

  High-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in neuronal cultures for mechanistic and drug discovery studies

  Current Protocols in Neuroscience. 2012;1(SUPPL.60).
  1

• 16.

  2012

  Debomoy K. Lahiri

  Prions: A piece of the puzzle?

  Science. 2012;337(6099):1172.
  1

• 17.

  2012

  Justin M. Long; Balmiki Ray; Debomoy K. Lahiri

  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients

  Journal of Biological Chemistry. 2012;287(37):31298-31310.
  1

• 18.

  2012

  Debomoy K Lahiri; Bryan Maloney

  Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS)

  Epigenomics. 2012;4(6):685-699.
  0

• 19.

  2011

  Jack T. Rogers; Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Deborah H. Smith; Xudong Huang; Sanghamitra Bandyopadhyay; Catherine M. Cahill; Maria L. Maccecchini; Debomoy K. Lahiri; Nigel H. Greig

  The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

  Journal of Neural Transmission. 2011:1-15.
  0

• 20.

  2011

  Balmiki Ray; Savita Bisht; Amarnath Maitra; Anirban Maitra; Debomoy K. Lahiri

  Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: Implications for Alzheimer's disease

  Journal of Alzheimer's Disease. 2011;23(1):61-77.
  22

• 21.

  2011

  Debomoy K. Lahiri

  An integrated approach to genome studies

  Science. 2011;331(6014):146.
  5

• 22.

  2011

  Justin M. Long; Debomoy K. Lahiri

  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed

  Biochemical and Biophysical Research Communications. 2011;404(4):889-895.
  32

• 23.

  2011

  Debomoy K. Lahiri

  Application of a multidisciplinary approach to Alzheimer's disease to develop novel drug targets by integrating biomarkers, imaging, genetic and molecular strategies

  Current Alzheimer Research. 2011;8(1):1-3.
  1

• 24.

  2011

  Debomoy K Lahiri

  An integrated approach to genome studies.

  Science (New York, N.Y.). 2011;331(6014):147.
  1

• 25.

  2011

  Balmiki Ray; Patricio F. Reyes; Debomoy K. Lahiri

  Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau

  Journal of Psychiatric Research. 2011;45(4):539-547.
  5

• 26.

  2011

  Balmiki Ray; Neelima B. Chauhan; Debomoy K. Lahiri

  Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl- l -cysteine treatment in the neuronal culture and APP-Tg mouse model

  Journal of Neurochemistry. 2011;117(3):388-402.
  8

• 27.

  2011

  Kumar Sambamurti; Nigel H. Greig; Tadanobu Utsuki; Eliza L. Barnwell; Ekta Sharma; Cheryl Mazell; Narayan R. Bhat; Mark S. Kindy; Debomoy K. Lahiri; Miguel A. Pappolla

  Targets for AD treatment: Conflicting messages from γ-secretase inhibitors

  Journal of Neurochemistry. 2011;117(3):359-374.
  26

• 28.

  2011

  D.K. Sokol; B. Maloney; J.M. Long; B. Ray; D.K. Lahiri

  Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links

  Neurology. 2011;76(15):1344-1352.
  18

• 29.

  2011

  B. Ray; D.L. Gaskins; T.J. Sajdyk; J.P. Spence; S.D. Fitz; A. Shekhar; D.K. Lahiri

  Restraint stress and repeated corticotrophin-releasing factor receptor activation in the amygdala both increase amyloid-β precursor protein and amyloid-β peptide but have divergent effects on brain-derived neurotrophic factor and pre-synaptic proteins in the prefrontal cortex of rats

  Neuroscience. 2011;184:139-150.
  6

• 30.

  2011

  Balmiki Ray; Justin M. Long; Deborah K. Sokol; Debomoy K. Lahiri

  Increased secreted Amyloid precursor protein-α (sappα) in severe Autism: Proposal of a specific, Anabolic pathway and putative biomarker

  PLoS ONE. 2011;6(6).
  9

• 31.

  2011

  Weiming Luo; Qian-Sheng Yu; Isidro Salcedo; Harold W. Holloway; Debomoy K. Lahiri; Arnold Brossi; David Tweedie; Nigel H. Greig

  Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity

  Bioorganic and Medicinal Chemistry. 2011;19(13):3965-3972.
  4

• 32.

  2011

  S.M. Kurian; H. Le-Niculescu; S.D. Patel; D. Bertram; J. Davis; C. Dike; N. Yehyawi; P. Lysaker; J. Dustin; M. Caligiuri; et al.

  Identification of blood biomarkers for psychosis using convergent functional genomics

  Molecular Psychiatry. 2011;16(1):37-58.
  26

• 33.

  2011

  Jason A. Bailey; Balmiki Ray; Nigel H. Greig; Debomoy K. Lahiri

  Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons

  PLoS ONE. 2011;6(7).
  13

• 34.

  2011

  J.M. Long; D.K. Lahiri

  Current drug targets for modulating Alzheimer's amyloid precursor protein: Role of specific micro-RNA species

  Current Medicinal Chemistry. 2011;18(22):3314-3321.
  4

• 35.

  2011

  B. Ray; N.B. Chauhan; D.K. Lahiri

  The "aged Garlic Extract" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD)

  Current Medicinal Chemistry. 2011;18(22):3306-3313.
  4

• 36.

  2011

  Jack T Rogers; Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Deborah H Smith; Xudong Huang; Sanghamitra Bandyopadhyay; Catherine M Cahill; Maria L Maccecchini; Debomoy K Lahiri; Nigel H Greig

  The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

  Journal of neural transmission (Vienna, Austria : 1996). 2011;118(3):493-507.
  11

• 37.

  2011

  Savita Bisht; Mehtab A. Khan; Mena Bekhit; Haibo Bai; Toby Cornish; Masamichi Mizuma; Michelle A. Rudek; Ming Zhao; Amarnath Maitra; Balmiki Ray; et al.

  A polymeric nanoparticle formulation of curcumin (NanoCurc) ameliorates CCl 4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation

  Laboratory Investigation. 2011;91(9):1383-1395.
  8

• 38.

  2011

  Jason A. Bailey; Bryan Maloney; Yuan-Wen Ge; Debomoy K. Lahiri

  Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis

  Gene. 2011;488(1-2):13-22.
  13

• 39.

  2011

  Bryan Maloney; Debomoy K. Lahiri

  The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motif

  Gene. 2011;488(1-2):1-12.
  10

• 40.

  2010

  Dong Liu; Michael Pitta; Jong-Hwan Lee; Balmiki Ray; Debomoy K. Lahiri; Katsutoshi Furukawa; Mohamed Mughal; Haiyang Jiang; Julissa Villarreal; Roy G. Cutler; et al.

  The KATP channel activator diazoxide ameliorates amyloid-β and Tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease

  Journal of Alzheimer's Disease. 2010;22(2):443-457.
  13

• 41.

  2010

  Debomoy K. Lahiri; Bryan Maloney

  The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps

  Experimental Gerontology. 2010;45(4):291-296.
  19

• 42.

  2010

  Stephen C. Bondy; Huihui Li; Jun Zhou; Meixia Wu; Jason A. Bailey; Debomoy K. Lahiri

  Melatonin alters age-related changes in transcription factors and kinase activation

  Neurochemical Research. 2010;35(12):2035-2042.
  2

• 43.

  2010

  Uwe Konietzko; Zoë V. Goodger; Michelle Meyer; Bernhard M. Kohli; Jérôme Bosset; Debomoy K. Lahiri; Roger M. Nitsch

  Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories

  Neurobiology of Aging. 2010;31(1):58-73.
  24

• 44.

  2010

  Bryan Maloney; Yuan-Wen Ge; Ronald C. Petersen; John Hardy; Jack T. Rogers; Jordi Pérez-Tur; Debomoy K. Lahiri

  Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions

  American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2010;153(1):185-201.
  12

• 45.

  2010

  George M. Alley; Jason A. Bailey; DeMao Chen; Balmiki Ray; Lakshman K. Puli; Heikki Tanila; Pradeep K. Banerjee; Debomoy K. Lahiri

  Memantine lowers amyloid-β peptide levels in neuronal cultures and in APP/PS1 transgenic mice

  Journal of Neuroscience Research. 2010;88(1):143-154.
  27

• 46.

  2010

  Balmiki Ray; Pradeep K. Banerjee; Nigel H. Greig; Debomoy K. Lahiri

  Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells

  Neuroscience Letters. 2010;470(1):1-5.
  15

• 47.

  2010

  Jason A. Bailey; Debomoy K. Lahiri

  A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease

  Journal of Neurochemistry. 2010;112(4):843-853.
  19

• 48.

  2010

  Debomoy K. Lahiri

  'Current Alzheimer Research' helps accelerate the progress of the field

  Current Alzheimer Research. 2010;7(1):1-2.
  1

• 49.

  2010

  Yazhou Li; Kara B. Duffy; Mary Ann Ottinger; Balmiki Ray; Jason A. Bailey; Harold W. Holloway; David Tweedie; Tracyann Perry; Mark P. Mattson; Dimitrios Kapogiannis; et al.

  GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease

  Journal of Alzheimer's Disease. 2010;19(4):1205-1219.
  49

• 50.

  2010

  S.D. Patel; H. Le-Niculescu; D.L. Koller; S.D. Green; D.K. Lahiri; F.J. McMahon; J.I. Nurnberger Jr.; A.B. Niculescu III

  Coming to grips with complex disorders: Genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics

  American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2010;153(4):850-877.
  23

• 51.

  2010

  Debomoy K. Lahiri

  Editorial-"Current aging science": An important platform for reporting advances in aging-related research

  Current Aging Science. 2010;3(1):1-2.
  1

• 52.

  2010

  Nigel H. Greig; R.E. Becker; Q. Yu; H.W. Holloway; D. Tweedie; W. Luo; T. Utsuki; D.K. Ingram; M.L. Maccecchini; et al.

  From natural products to Alzheimer experimental therapeutics, eserine based drugs as symptomatic and disease altering agents

  Progress in Nutrition. 2010;12(1):58-63.
  0

• 53.

  2010

  Qian-Sheng Yu; Harold W. Holloway; Weiming Luo; Debomoy K. Lahiri; Arnold Brossi; Nigel H. Greig

  Long-acting anticholinesterases for myasthenia gravis: Synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine

  Bioorganic and Medicinal Chemistry. 2010;18(13):4687-4693.
  6

• 54.

  2010

  Debomoy K. Lahiri; Bryan Maloney

  Beyond the signaling effect role of amyloid-β₄₂ on the processing of APP, and its clinical implications

  Experimental Neurology. 2010;225(1):51-54.
  8

• 55.

  2010

  Sanghamitra Bandyopadhyay; Xudong Huang; Debomoy K. Lahiri; Jack T. Rogers

  Novel drug targets based on metallobiology of Alzheimer's disease

  Expert Opinion on Therapeutic Targets. 2010;14(11):1177-1197.
  17

• 56.

  2009

  Debomoy K. Lahiri

  Editorial - progress and vision for 'current aging science'

  Current Aging Science. 2009;2(1):1-2.
  0

• 57.

  2009

  Balmiki Ray; Jay R. Simon; Debomoy K. Lahiri

  Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells

  Brain Research. 2009;1297:160-168.
  7

• 58.

  2009

  Debomoy K. Lahiri

  A smart plan for new investigators

  Science. 2009;326(5955):935-936.
  0

• 59.

  2009

  Yazhou Li; TracyAnn Perry; Mark S. Kindy; Brandon K. Harvey; David Tweedie; Harold W. Holloway; Kathleen Powers; Hui Shen; Josephine M. Egan; Kumar Sambamurti; et al.

  GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

  Proceedings of the National Academy of Sciences of the United States of America. 2009;106(4):1285-1290.
  72

• 60.

  2009

  Lon S. Schneider; Debomoy K. Lahiri

  The perils of Alzheimer's drug development

  Current Alzheimer Research. 2009;6(1):77-78.
  12

• 61.

  2009

  Debomoy K. Lahiri

  Celebrating the fifth year anniversary of current Alzheimer research

  Current Alzheimer Research. 2009;6(1):1-3.
  2

• 62.

  2009

  Bryan Maloney; Balmiki Ray; Elizabeth R. Hayden; John I. Nurnberger Jr.; Debomoy K. Lahiri

  Development and validation of the high-quality 'rapid method for swab' to genotype the HTTLPR serotonin transporter (SLC6A4) promoter DOlvmorDhism

  Psychiatric Genetics. 2009;19(2):72-82.
  1

• 63.

  2009

  Nasser H. Zawia; Debomoy K. Lahiri; Fernando Cardozo-Pelaez

  Epigenetics, oxidative stress, and Alzheimer disease

  Free Radical Biology and Medicine. 2009;46(9):1241-1249.
  95

• 64.

  2009

  Ana Martínez; Debomoy K. Lahiri; Ezio Giacobini; Nigel H. Greig

  Advances in alzheimer therapy:Understanding Pharmacological approaches to the disease

  Current Alzheimer Research. 2009;6(2):83-85.
  6

• 65.

  2009

  Catherine M. Cahill; Debomoy K. Lahiri; Xudong Huang; Jack T. Rogers

  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

  Biochimica et Biophysica Acta - General Subjects. 2009;1790(7):615-628.
  14

• 66.

  2009

  Balmiki Ray; Debomoy K Lahiri

  Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin

  Current Opinion in Pharmacology. 2009;9(4):434-444.
  42

• 67.

  2009

  Debomoy K. Lahiri

  Perspective on Mild Cognitive Impairment (MCI)

  Current Alzheimer Research. 2009;6(4):322.
  0

• 68.

  2009

  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md. Riyaz Basha; Christopher A. McPherson; G. Jean Harry; Deborah C. Rice; Nasser H. Zawia; et al.

  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice

  Journal of Alzheimer's Disease. 2009;18(1):211-230.
  12

• 69.

  2009

  Balmiki Ray; Jason A. Bailey; Sumit Sarkar; Debomoy K. Lahiri

  Molecular and immunocytochemical characterization of primary neuronal cultures from adult rat brain: Differential expression of neuronal and glial protein markers

  Journal of Neuroscience Methods. 2009;184(2):294-302.
  8

• 70.

  2009

  D.K. Lahiri; B. Maloney; N.H. Zawia

  The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases

  Molecular Psychiatry. 2009;14(11):992-1003.
  48

• 71.

  2009

  Debomoy K Lahiri

  Progress and vision for 'Current Aging Science'.

  Current aging science. 2009;2(1):1-2.
  1

• 72.

  2008

  Jinfang Wu; Md. Riyaz Basha; Brian Brock; David P. Cox; Fernando Cardozo-Pelaez; Christopher A. McPherson; Jean Harry; Deborah C. Rice; Bryan Maloney; et al.

  Alzheimer's Disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): Evidence for a developmental origin and environmental link for AD

  Journal of Neuroscience. 2008;28(1):3-9.
  109

• 73.

  2008

  Elizabeth P. Hayden; Lea R. Dougherty; Bryan Maloney; Thomas M. Olino; Haroon Sheikh; C. Emily Durbin; John I. Nurnberger Jr.; Debomoy K. Lahiri; Daniel N. Klein

  Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism

  Journal of Affective Disorders. 2008;107(1-3):227-230.
  33

• 74.

  2008

  Yi Wen; W. Haung Yu; Bryan Maloney; Jason Bailey; Junrong Ma; Isabelle Marié; Thomas Maurin; Lili Wang; Helen Figueroa; Mathieu Herman; et al.

  Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing

  Neuron. 2008;57(5):680-690.
  83

• 75.

  2008

  Brian Brock; Riyaz Basha; Katie DiPalma; Amy Anderson; G. Jean Harry; Deborah C. Rice; Bryan Maloney; Debomoy K. Lahiri; Nasser H. Zawia

  Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis

  Journal of Alzheimer's Disease. 2008;13(1):71-80.
  9

• 76.

  2008

  Debomoy K. Lahiri

  Progress of 'Current Alzheimer Research' and update on roles of lipids, estrogen, neurotrophins and cytokines in Alzheimer's disease

  Current Alzheimer Research. 2008;5(1):1-3.
  0

• 77.

  2008

  Debomoy K Lahiri

  'Current Alzheimer Research': update on lipids, estrogen, neurotrophins and their roles in neurodegeneration.

  Current Alzheimer research. 2008;5(1):1-3.
  3

• 78.

  2008

  Debomoy K. Lahiri; Nasser H. Zawia; Nigel H. Greig; Kumar Sambamurti; Bryan Maloney

  Early-life events may trigger biochemical pathways for Alzheimer's disease: The "LEARn" model

  Biogerontology. 2008;9(6):375-379.
  21

• 79.

  2008

  M.K. Thakur; Renu Wadhwa; D.K. Lahiri

  Editorial: Special issue of Biogerontology on brain aging

  Biogerontology. 2008;9(6):367-368.
  0

• 80.

  2008

  Jack T. Rogers; Ashley I. Bush; Hyan-Hee Cho; Deborah H. Smith; Andrew M. Thomson; Avi L. Friedrlich; Debomoy K. Lahiri; Peter J. Leedman; Xudong Huang; Catherine M. Cahill

  Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: Riboregulation against neural oxidative damage in Alzheimer's disease

  Biochemical Society Transactions. 2008;36(6):1282-1287.
  29

• 81.

  2008

  Debomoy K Lahiri

  A new journal with an integrated approach in the study of aging and longevity.

  Current aging science. 2008;1(1):1-3.
  3

• 82.

  2007

  Edward H. Sharman; Stephen C. Bondy; Kaizhi G. Sharman; Debomoy Lahiri; Carl W. Cotman; Victoria M. Perreau

  Effects of melatonin and age on gene expression in mouse CNS using microarray analysis

  Neurochemistry International. 2007;50(2):336-344.
  15

• 83.

  2007

  Debomoy K. Lahiri; Bryan Maloney; Md. Riyaz Basha; Wen Ge Yuan; Nasser H. Zawia

  How and when environmental agents and dietary factors affect the course of Alzheimer's disease: The "LEARn" model (Latent Early-Life Associated Regulation) may explain the triggering of AD

  Current Alzheimer Research. 2007;4(2):219-228.
  39

• 84.

  2007

  Debomoy K. Lahiri; DeMao Chen; Bryan Maloney; Harold W. Holloway; Qian-Sheng Yu; Tada Utsuki; Tony Giordano; Kumar Sambamurti; Nigel H. Greig

  The experimental Alzheimer's Disease drug posiphen [(+)-phenserine] lowers amyloid-β peptide levels in cell culture and mice

  Journal of Pharmacology and Experimental Therapeutics. 2007;320(1):386-396.
  45

• 85.

  2007

  Michael C. Veronesi; Michael Yard; James Jackson; Debomoy K. Lahiri; Michael J. Kubek

  An analog of thyrotropin-releasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro

  Brain Research. 2007;1128(1):79-85.
  8

• 86.

  2007

  Debomoy K. Lahiri

  Alzheimer's disease: Highlights from research on hormones, growth factors and signaling pathways

  Current Alzheimer Research. 2007;4(1):1-2.
  1

• 87.

  2007

  David Tweedie; Anat Milman; Harold W. Holloway; Yazhou Li; Brandon K. Harvey; Hui Shen; Paul J. Pistell; Debomoy K. Lahiri; Barry J. Hoffer; Yun Wang; et al.

  Apoptotic and behavioral sequelae of mild brain trauma in mice

  Journal of Neuroscience Research. 2007;85(4):805-815.
  27

• 88.

  2007

  Elizabeth P. Hayden; Lea R. Dougherty; Bryan Maloney; C. Emily Durbin; Thomas M. Olino; John I. Nurnberger Jr.; Debomoy K. Lahiri; Daniel N. Klein

  Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: A multimethod association study

  Psychiatric Genetics. 2007;17(3):135-142.
  24

• 89.

  2007

  Debomoy K. Lahiri; George M. Alley; David Tweedie; Demao Chen; Nigel H. Greig

  Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer disease

  NeuroMolecular Medicine. 2007;9(2):157-168.
  6

• 90.

  2007

  Stephen G. Rice; Lee Nowak; Ellen G. Duysen; Oksana Lockridge; Debomoy K. Lahiri; Patricio F. Reyes

  Neuropathological and immunochemical studies of brain parenchyma in acetylcholinesterase knockout mice: Implications in Alzheimer's disease

  Journal of Alzheimer's Disease. 2007;11(4):481-489.
  5

• 91.

  2007

  Nigel H. Greig; Ezio Giacobini; Debomoy K. Lahiri

  Advances in Alzheimer therapy and development of innovative new strategies

  Current Alzheimer Research. 2007;4(4):336-339.
  8

• 92.

  2007

  Bryan Maloney; Yuan-Wen Ge; George M. Alley; Debomoy K. Lahiri

  Important differences between human and mouse APOE gene promoters: Limitation of mouse APOE model in studying Alzheimer's disease

  Journal of Neurochemistry. 2007;103(3):1237-1257.
  11

• 93.

  2007

  S. Bandyopadhyay; L.E. Goldstein; D.K. Lahiri; J.T. Rogers

  Role of the APP non-amyloidogenic signaling pathway and targeting α-secretase as an alternative drug target for treatment of Alzheimer's diseases

  Current Medicinal Chemistry. 2007;14(27):2848-2864.
  28

• 94.

  2006

  Jason A. Bailey; Debomoy K. Lahiri

  Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: Implications in neuronal plasticity and Alzheimer's disease

  Annals of the New York Academy of Sciences. 2006;1086:54-65.
  9

• 95.

  2006

  Gen Sobue; Masahide Takahashi; Jun Yoshida; Kozo Kaibuchi; Tomoki Naoe; Debomoy K. Lahiri

  Integrated molecular medicine for neuronal and neoplastic disorders

  Annals of the New York Academy of Sciences. 2006;1086:xi-xii.
  0

• 96.

  2006

  Debomoy K. Lahiri; Frank M. LaFerla

  Marking the centennial of Alzheimer's first report of the disease with a perspective of ongoing research and future challenge

  Current Alzheimer Research. 2006;3(5):409-410.
  1

• 97.

  2006

  Debomoy K. Lahiri; Bryan Maloney

  Genes are not our destiny: The somatic epitype bridges between the genotype and the phenotype

  Nature Reviews Neuroscience. 2006;7(12).
  9

• 98.

  2006

  Debomoy K. Lahiri; Yuan-Wen Ge; Jack T. Rogers; Kumar Sambamurti; Nigel H. Greig; Bryan Maloney

  Taking down the unindicted co-conspirators of amyloid β- peptide-mediated neuronal death: Shared gene regulation of BACE1 and APP genes interacting with CREB, Fe65 and YY1 transcription factors

  Current Alzheimer Research. 2006;3(5):475-483.
  14

• 99.

  2006

  David Tweedie; Arnold Brossi; DeMoa Chen; Yuan-Wen Ge; Jason Bailey; Qian-Sheng Yu; Mohammad A. Kamal; Kumar Sambamurti; Debomoy K. Lahiri; Nigel H. Greig

  Neurine, an acetylcholine autolysis product, elevates secreted amyloid-β protein precursor and amyloid-β peptide levels, and lowers neuronal cell viability in culture: A role in Alzheimer's disease?

  Journal of Alzheimer's Disease. 2006;10(1):9-16.
  4

• 100.

  2006

  Debomoy K. Lahiri

  Discourse among referees and editors would help [8]

  Nature. 2006;439(7078):784.
  0

• 101.

  2006

  Weiming Luo; Qian-Sheng Yu; Santosh S. Kulkarni; Damon A. Parrish; Harold W. Holloway; David Tweedie; Avigdor Shafferman; Debomoy K. Lahiri; Arnold Brossi; et al.

  Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine

  Journal of Medicinal Chemistry. 2006;49(7):2174-2185.
  23

• 102.

  2006

  Debomoy K. Lahiri

  Editorial- Update on Current Alzheimer Research

  Current Alzheimer Research. 2006;3(2):93-94.
  0

• 103.

  2006

  Kumar Sambamurti; Anitha Suram; Chitra Venugopal; Annamalai Prakasam; Yan Zhou; Debomoy K. Lahiri; Nigel H. Greig

  A partial failure of membrane protein turnover may cause Alzheimer's disease: A new hypothesis

  Current Alzheimer Research. 2006;3(1):81-90.
  36

• 104.

  2006

  Debomoy K. Lahiri

  Editorial - A milestone for current Alzheimer research

  Current Alzheimer Research. 2006;3(1):1.
  0

• 105.

  2006

  Celeste M. Bolin; Riyaz Basha; David Cox; Nasser H. Zawia; Bryan Maloney; Debomoy K. Lahiri; Fernando Cardozo-Pelaez

  Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain

  FASEB Journal. 2006;20(6):788-790.
  64

• 106.

  2006

  Kari L. Kernek; James A. Trofatter; Aimee R. Mayeda; Debomoy K. Lahiri; John R. Hofstetter

  A single copy of Carbonic anhydrase 2 restores wild-type circadian period to carbonic anhydrase II-deficient mice

  Behavior Genetics. 2006;36(2):301-308.
  3

• 107.

  2006

  Debomoy K. Lahiri; Bryan Maloney; Yuan-Wen Ge

  BACE1 gene promoter is differentially regulated: Detection of a novel promoter region for its cell type-specific regulation

  Journal of Molecular Neuroscience. 2006;28(2):193-210.
  12

• 108.

  2006

  Debomoy K. Lahiri; Bryan Maloney; Yuan-Wen Ge

  Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells

  Journal of Molecular Neuroscience. 2006;29(1):65-80.
  18

• 109.

  2006

  Bryan Maloney; Yuan-Wen Ge; Nigel H. Greig; Debomoy K. Lahiri

  Characterization of the human β-secretase 2 (BACE2) 5′-flanking region: Identification of a 268-bp region as the basal BACE2 promoter

  Journal of Molecular Neuroscience. 2006;29(1):81-99.
  14

• 110.

  2006

  Sanghamitra Bandyopadhyay; Dean M. Hartley; Catherine M. Cahill; Debomay K. Lahiri; Naibedya Chattopadhyay; Jack T. Rogers

  Interleukin-1α stimulates non-amyloidogenic pathway by α-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase

  Journal of Neuroscience Research. 2006;84(1):106-118.
  28

• 111.

  2006

  Tada Utsuki; Qian-Sheng Yu; Diane Davidson; Demao Chen; Harold W. Holloway; Arnold Brossi; Kumar Sambamurti; Debomoy K. Lahiri; Nigel H. Greig; Tony Giordano

  Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-β peptide

  Journal of Pharmacology and Experimental Therapeutics. 2006;318(2):855-862.
  14

• 112.

  2006

  Angelica Becaria; Debomoy K. Lahiri; Stephen C. Bondy; DeMao Chen; Ali Hamadeh; Huihui Li; Russell Taylor; Arezoo Campbell

  Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain

  Journal of Neuroimmunology. 2006;176(1-2):16-23.
  44

• 113.

  2006

  Deborah K. Sokol; Demao Chen; Martin R. Farlow; David W. Dunn; Bryan Maloney; Jennifer A. Zimmer; Debomoy K. Lahiri

  High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression

  Journal of Child Neurology. 2006;21(6):444-449.
  21

• 114.

  2006

  Debomoy K. Lahiri

  Where the actions of environment (nutrition), gene and protein meet: Beneficial role of fruit and vegetable juices in potentially delaying the onset of Alzheimer's disease

  Journal of Alzheimer's Disease. 2006;10(4):359-361.
  6

• 115.

  2005

  Debomoy K. Lahiri

  Editorial - The A's and M's of Alzheimer's disease

  Current Alzheimer Research. 2005;2(4):387.
  0

• 116.

  2005

  Debomoy K. Lahiri

  Editorial - Progress of Current Alzheimer Research

  Current Alzheimer Research. 2005;2(1):1-2.
  0

• 117.

  2005

  Debomoy K. Lahiri; Yuan-Wen Ge; Bryan Maloney; Fabienne Wavrant-De Vrièze; John Hardy

  Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease

  Neurobiology of Aging. 2005;26(10):1329-1341.
  20

• 118.

  2005

  Nigel H. Greig; Tadanobu Utsuki; Donald K. Ingram; Yue Wang; Giancarlo Pepeu; Carla Scali; Qian-Sheng Yu; Jacek Mamczarz; Harold W. Holloway; Tony Giordano; et al.

  Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

  Proceedings of the National Academy of Sciences of the United States of America. 2005;102(47):17213-17218.
  169

• 119.

  2005

  Debomoy K. Lahiri

  Editorial - Advances of Alzheimer's disease research: Crossroad of basic and translational studies

  Current Alzheimer Research. 2005;2(5):495-496.
  0

• 120.

  2005

  Md. Riyaz Basha; Manjari Murali; Hasan K. Siddiqi; Koyel Ghosal; Omar K. Siddiqi; Hilal A. Lashuel; Yuan-Wen Ge; Debomoy K. Lahiri; N.H. Zawia

  Lead (Pb) exposure and its effect on APP proteolysis and Aβ aggregation

  FASEB Journal. 2005;19(14):2083-2084.
  29

• 121.

  2005

  Debomoy K. Lahiri; De-Mao Chen; Preeti Lahiri; Steve Bondy; Nigel H. Greig

  Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases

  Annals of the New York Academy of Sciences. 2005;1056:430-449.
  20

• 122.

  2005

  Girish Jayant Kotwal; Debomoy Kumar Lahiri

  Natural products and molecular therapy: Preface

  Annals of the New York Academy of Sciences. 2005;1056:xi-xiii.
  0

• 123.

  2005

  Zhouning Zhang; Melissa-Rose Abrahams; Lawrence A. Hunt; Jill Suttles; William Marshall; Debomoy K. Lahiri; Girish J. Kotwal

  The vaccinia virus N1L protein influences cytokine secretion in vitro after infection

  Annals of the New York Academy of Sciences. 2005;1056:69-86.
  12

• 124.

  2005

  M. Riyaz Basha; Wei Wei; Saleh A. Bakheet; Nathalie Benitez; Hasan K. Siddiqi; Yuan-Wen Ge; Debomoy K. Lahiri; Nasser H. Zawia

  The fetal basis of amyloidogenesis: Exposure to lead and latent overexpression of amyloid precursor protein and β-amyloid in the aging brain

  Journal of Neuroscience. 2005;25(4):823-829.
  99

• 125.

  2005

  Weiming Luo; Qian-Sheng Yu; Ming Zhan; Damon Parrish; Jeffrey R. Deschamps; Santosh S. Kulkarni; Harold W. Holloway; George M. Alley; Debomoy K. Lahiri; Arnold Brossi; et al.

  Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine

  Journal of Medicinal Chemistry. 2005;48(4):986-994.
  24

• 126.

  2005

  Debomoy K. Lahiri; Yuan-Wen Ge; Bryan Maloney

  Characterization of the APP proximal promoter and 5′-untranslated regions: Identification or cell type-specific domains and implications in APP gene expression and Alzheimer's disease

  FASEB Journal. 2005;19(6):653-655.
  28

• 127.

  2005

  Yansheng Du; Xianming Chen; Xing Wei; Kelly R. Bales; David T. Berg; Steven M. Paul; Martin R. Farlow; Bryan Maloney; Yuan-Wen Ge; et al.

  NF-κB mediates amyloid β peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells

  Molecular Brain Research. 2005;136(1-2):177-188.
  12

• 128.

  2005

  Nigel H. Greig; Debomoy K. Lahiri; Ezio Giacobini

  Editorial: Advances in Alzheimer therapy: Something old, something new, something borrowed, something blue

  Current Alzheimer Research. 2005;2(3):275-278.
  4

• 129.

  2005

  Nigel H. Greig; Kumar Sambamurti; Qian-Sheng Yu; Arnold Brossi; Gosse B. Bruinsma; Debomoy K. Lahiri

  An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

  Current Alzheimer Research. 2005;2(3):281-290.
  52

• 130.

  2005

  Y. Nie; D.D. Schoepp; J.E. Klaunig; M. Yard; D.K. Lahiri; M.J. Kubek

  Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro

  Brain Research. 2005;1054(1):45-54.
  7

• 131.

  2004

  Debomoy K Lahiri

  Advances in the four major pillars of Alzheimer's disease research: pathobiology, genetics, diagnosis, and treatment.

  Curr Alzheimer Res. 2004;1(3):i-ii.
  1

• 132.

  2004

  Amanda Venti; Tony Giordano; Paul Eder; Ashley I. Bush; Debomoy K. Lahiri; Nigel H. Greig; Jack T. Rogers

  Integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5′-untranslated region

  Annals of the New York Academy of Sciences. 2004;1035:34-48.
  28

• 133.

  2004

  David N. Reynolds; Scott A. Smith; Yi P. Zhang; Qiu Mengsheng; Debomoy K. Lahiri; Dante J. Morassutti; Christopher B. Shields; Girish J. Kotwal

  Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury

  Annals of the New York Academy of Sciences. 2004;1035:165-178.
  20

• 134.

  2004

  S.C. Bondy; D.K. Lahiri; V.M. Perreau; K.Z. Sharman; A. Campbell; J. Zhou; E.H. Sharman

  Retardation of brain aging by chronic treatment with melatonin

  Annals of the New York Academy of Sciences. 2004;1035:197-215.
  13

• 135.

  2004

  Debomoy K. Lahiri; Demao Chen; Preeti Lahiri; Jack T. Rogers; Nigel H. Greig; Stephen Bondy

  Melatonin, metals, and gene expression: Implications in aging and neurodegenerative disorders

  Annals of the New York Academy of Sciences. 2004;1035:216-230.
  11

• 136.

  2004

  Nigel H. Greig; Mark P. Mattson; Tracyann Perry; Sic L. Chan; Tony Giordano; Kumar Sambamurti; Jack T. Rogers; Haim Ovadia; Debomoy K. Lahiri

  New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-α inhibitors, and GLP-1 receptor agonists

  Annals of the New York Academy of Sciences. 2004;1035:290-315.
  32

• 137.

  2004

  Amod P. Kulkarni; Laurie A. Kellaway; Debomoy K. Lahiri; Girish J. Kotwal

  Neuroprotection from complement-mediated inflammatory damage

  Annals of the New York Academy of Sciences. 2004;1035:147-164.
  26

• 138.

  2004

  Debomoy K. Lahiri

  Preface: Current research trend on neurodegeneration, neuroinflammation, and neuroprotection

  Annals of the New York Academy of Sciences. 2004;1035:ix-xiii.
  0

• 139.

  2004

  Debomoy K. Lahiri

  Functional characterization of amyloid β precursor protein regulatory elements: Rationale for the identification of genetic polymorphism

  Annals of the New York Academy of Sciences. 2004;1030:282-288.
  7

• 140.

  2004

  B. Billings; S.A. Smith; Z. Zhang; D.K. Lahiri; Girish J. Kotwal

  Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain

  Annals of the New York Academy of Sciences. 2004;1030:297-302.
  13

• 141.

  2004

  Debomoy K. Lahiri; Yuan-Wen Ge

  Role of the APP promoter in Alzheimer's disease: Cell type-specific expression of the β-amyloid precursor protein

  Annals of the New York Academy of Sciences. 2004;1030:310-316.
  14

• 142.

  2004

  Debomoy K. Lahiri

  Alzheimer's disease - Current trends in basic and clinical research. Highlights from the 16th ECNP

  Expert Opinion on Investigational Drugs. 2004;13(1):79-86.
  1

• 143.

  2004

  Edward H. Sharman; Kaizhi G. Sharman; Yuan-Wen Ge; Debomoy K. Lahiri; Stephen C. Bondy

  Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin

  Journal of Pineal Research. 2004;36(3):165-170.
  27

• 144.

  2004

  Debomoy K. Lahiri; Yuan-Wen Ge; Edward H. Sharman; Stephen C. Bondy

  Age-related changes in serum melatonin in mice: Higher levels of combined melatonin and 6-hydroxymelatonin sulfate in the cerebral cortex than serum, heart, liver and kidney tissues

  Journal of Pineal Research. 2004;36(4):217-223.
  39

• 145.

  2004

  Debomoy K. Lahiri; Demao Chen; Yuan-Wen Ge; Stephen C. Bondy; Edward H. Sharman

  Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex

  Journal of Pineal Research. 2004;36(4):224-231.
  40

• 146.

  2004

  Shayne A. Bellingham; Debomoy K. Lahiri; Bryan Maloney; Sharon La Fontaine; Gerd Multhaup; James Camakaris

  Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene

  Journal of Biological Chemistry. 2004;279(19):20378-20386.
  89

• 147.

  2004

  R.M. Evans; S. Hui; A. Perkins; D.K. Lahiri; J. Poirier; M.R. Farlow

  Cholesterol and APOE genotype interact to influence Alzheimer disease progression

  Neurology. 2004;62(10):1869-1871.
  51

• 148.

  2004

  Debomoy K. Lahiri; Kumar Sambamurti; David A. Bennett

  Apolipoprotein gene and its interaction with the environmentally driven risk factors: Molecular, genetic and epidemiological studies of Alzheimer's disease

  Neurobiology of Aging. 2004;25(5):651-660.
  60

• 149.

  2004

  Debomoy K. Lahiri; Nigel H. Greig

  Lethal weapon: Amyloid β-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease

  Neurobiology of Aging. 2004;25(5):581-587.
  15

• 150.

  2004

  Kumar Sambamurti; Ann-Charlotte Granholm; Mark S. Kindy; Narayan R. Bhat; Nigel H. Greig; Debomoy K. Lahiri; Jacobo E. Mintzer

  Cholesterol and Alzheimer's disease: Clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors

  Current Drug Targets. 2004;5(6):517-528.
  40

• 151.

  2004

  Debomoy K. Lahiri

  Preface: Highlights of recent progress in Alzheimer's disease research

  Current Drug Targets. 2004;5(6):xxx.
  0

• 152.

  2004

  Jack T. Rogers; Debomoy K. Lahiri

  Metal and inflammatory targets for Alzheimer's disease

  Current Drug Targets. 2004;5(6):535-551.
  82

• 153.

  2004

  Debomoy K Lahiri

  Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene.

  Journal of molecular neuroscience : MN. 2004;23(3):225-233.
  33

• 154.

  2004

  Yuan-Wen Ge; Chandramallika Ghosh; Weihong Song; Bryan Maloney; Debomoy K. Lahiri

  Mechanism of promoter activity of the β-amyloid precursor protein gene in different cell lines: Identification of a specific 30 bp fragment in the proximal promoter region

  Journal of Neurochemistry. 2004;90(6):1432-1444.
  17

• 155.

  2004

  D.K. Lahiri; J.T. Rogers; N.H. Greig; K. Sambamurti

  Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents

  Current Pharmaceutical Design. 2004;10(25):3111-3119.
  46

• 156.

  2004

  Kumar Sambamurti; Rachel Kinsey; Bryan Maloney; Yuan-Wen Ge; Debomoy K. Lahiri

  Gene structure and organization of the human β-secretase (BACE) promoter

  FASEB Journal. 2004;18(9):1034-1036.
  75

• 157.

  2004

  Yuan-Wen Ge; Bryan Maloney; Kumar Sambamurti; Debomoy K. Lahiri

  Functional characterization of the 5′ flanking region of the BACE gene: Identification of a 91 bp fragment involved in basal level of BACE promoter expression

  FASEB Journal. 2004;18(9):1037-1039.
  40

• 158.

  2004

  Bryan Maloney; Yuan-Wen Ge; Nigel Greig; Debomoy K. Lahiri

  Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: Implications in Alzheimer's disease

  FASEB Journal. 2004;18(11):1288-1290.
  30

• 159.

  2004

  Nigel H. Greig; Tony Giordano; Xiaoxiang Zhu; Qian-Sheng Yu; Tracy Ann Perry; Harold W. Holloway; Arnold Brossi; Jack T. Rogers; Kumar Sambamurti; Debomoy K. Lahiri

  Thalidomide-based TNF-α inhibitors for neurodegenerative diseases

  Acta Neurobiologiae Experimentalis. 2004;64(1):1-9.
  20

• 160.

  2004

  Xiaoxiang Zhu; Nigel H. Greig; Qian-sheng Yu; Tada Utsuki; Harold W. Holloway; Debomoy K. Lahiri; Arnold Brossi

  Synthesis of 3-alkylidene-isoindolinones via sulphide contraction

  Heterocycles. 2004;64:93-99.
  2

• 161.

  2004

  Arezoo Campbell; A. Becaria; D.K. Lahiri; K. Sharman; S.C. Bondy

  Chronic Exposure to Aluminum in Drinking Water Increases Inflammatory Parameters Selectively in the Brain

  Journal of Neuroscience Research. 2004;75(4):565-572.
  58

• 162.

  2003

  D.N. Reynolds; S.A. Smith; Y.-P. Zhang; D.K. Lahiri; D.J. Morassutti; C.B. Shields; G.J. Kotwal

  Vaccinia Virus Complement Control Protein Modulates Inflammation Following Spinal Cord Injury

  Annals of the New York Academy of Sciences. 2003;1010:534-539.
  10

• 163.

  2003

  A.G. Kanthasamy; M. Kitazawa; S. Kaul; Y. Yang; D.K. Lahiri; V. Anantharam; A. Kanthasamy

  Proteolytic Activation of Proapoptotic Kinase PKCδ Is Regulated by Overexpression of Bcl-2: Implications for Oxidative Stress and Environmental Factors in Parkinson's Disease

  Annals of the New York Academy of Sciences. 2003;1010:683-686.
  17

• 164.

  2003

  D.K. Lahiri; D. Chen; Y.-W. Ge; M. Farlow; G. Kotwal; A. Kanthasamy; D.K. Ingram; N.H. Greig

  Does Nitric Oxide Synthase Contribute to the Pathogenesis of Alzheimer's Disease? Effects of β-Amyloid Deposition on NOS in Transgenic Mouse Brain with AD Pathology

  Annals of the New York Academy of Sciences. 2003;1010:639-642.
  15

• 165.

  2003

  D.K. Lahiri; C. Ghosh; Y.-W. Ge

  A Proximal Gene Promoter Region for the β-Amyloid Precursor Protein Provides a Link between Development, Apoptosis, and Alzheimer's Disease

  Annals of the New York Academy of Sciences. 2003;1010:643-647.
  13

• 166.

  2003

  Debomoy K. Lahiri; Martin R. Farlow; Kumar Sambamurti; Nigel H. Greig; Ezio Giacobini; Lon S. Schneider

  A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

  Current Drug Targets. 2003;4(2):97-112.
  121

• 167.

  2003

  Laura Marlow; Rosa M. Canet; Sharie J. Haugabook; John A. Hardy; Debomoy K. Lahiri; Kumar Sambamurti

  APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity

  Biochemical and Biophysical Research Communications. 2003;305(3):502-509.
  29

• 168.

  2003

  TracyAnn Perry; Debomoy K. Lahiri; Kumar Sambamurti; Demao Chen; Mark P. Mattson; Josephine M. Egan; Nigel H. Greig

  Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron

  Journal of Neuroscience Research. 2003;72(5):603-612.
  123

• 169.

  2003

  D.K. Lahiri; D. Chen; D. Vivien; Y.-W. Ge; N.H. Greig; J.T. Rogers

  Role of cytokines in the gene expression of amyloid β-protein precursor: Identification of a 5′-UTR-binding nuclear factor and its implications in Alzheimer's disease

  Journal of Alzheimer's Disease. 2003;5(2):81-90.
  45

• 170.

  2003

  Sylvain Lesné; Fabian Docagne; Cecília Gabriel; Géraldine Liot; Debomoy K. Lahiri; Luc Buée; Laurent Plawinski; André Delacourte; Eric T. MacKenzie; Alain Buisson; et al.

  Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice

  Journal of Biological Chemistry. 2003;278(20):18408-18418.
  69

• 171.

  2003

  Laura Marlow; Rosa M. Canet; Sharie J. Haugabook; John A. Hardy; Debomoy K. Lahiri; Kumar Sambamurti

  Erratum: APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity (Biochemical and Biophysical Research Communications (2003) 305 (502-509))

  Biochemical and Biophysical Research Communications. 2003;307(3):756.
  0

• 172.

  2003

  Debomoy K. Lahiri

  6th International Conference on Alzheimer's Disease and Parkinson's Disease

  Expert Opinion on Investigational Drugs. 2003;12(8):1433-1440.
  1

• 173.

  2003

  Xiaoxiang Zhu; Tony Giordano; Qian-Sheng Yu; Harold W. Holloway; Tracy Ann Perry; Debomoy K. Lahiri; Arnold Brossi; Nigel H. Greig

  Thiothalidomides: Novel Isosteric Analogues of Thalidomide with Enhanced TNF-α Inhibitory Activity

  Journal of Medicinal Chemistry. 2003;46(24):5222-5229.
  35

• 174.

  2003

  Qian-Sheng Yu; Weiming Luo; Harold W. Holloway; Tada Utsuki; Tracy Ann Perry; Debomoy K. Lahiri; Nigel H. Greig; Arnold Brossi

  Racemic N¹-norphenserine and its enantiomers: Unpredicted inhibition of human acetyl- and butyrylcholinesterase and β-amyloid precursor protein in vitro

  Heterocycles. 2003;61:529-539.
  12

• 175.

  2003

  Debomoy K. Lahiri; Martin R. Farlow

  Review: Cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease: Commentary

  Evidence-Based Mental Health. 2003;6(3):94.
  0

• 176.

  2002

  Stephen C Bondy; Y.Ellen Yang; Thomas J Walsh; Yuan-Wen Gie; Debomoy K Lahiri

  Dietary modulation of age-related changes in cerebral pro-oxidant status

  Neurochemistry International. 2002;40(2):123-130.
  20

• 177.

  2002

  Tracyann Perry; Debomoy K. Lahiri; Demao Chen; J.I.E. Zhou; Karen T. Y. Shaw; Josephine M. Egan; Nigel H. Greig

  A novel neurotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells

  Journal of Pharmacology and Experimental Therapeutics. 2002;300(3):958-966.
  109

• 178.

  2002

  D.K. Lahiri; C. Nall; D. Chen; M. Zaphiriou; C. Morgan; J.I. Nurnberger Sr.

  Developmental expression of the β-amyloid precursor protein and heat-shock protein 70 in the cerebral hemisphere region of the rat brain

  Annals of the New York Academy of Sciences. 2002;965:324-333.
  8

• 179.

  2002

  D.K. Lahiri; T. Utsuki; D. Chen; M.R. Farlow; M. Shoaib; D.K. Ingram; N.H. Greig

  Nicotine reduces the secretion of Alzheimer's β-amyloid precursor protein containing β-amyloid peptide in the rat without altering synaptic proteins

  Annals of the New York Academy of Sciences. 2002;965:364-372.
  30

• 180.

  2002

  Kumar Sambamurti; Nigel H. Greig; Debomoy K. Lahiri

  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

  NeuroMolecular Medicine. 2002;1(1):1-31.
  138

• 181.

  2002

  Kumar Sambamurti; John Hardy; Lorenzo M. Refolo; Debomoy K. Lahiri

  Targeting APP metabolism for the treatment of Alzheimer's disease

  Drug Development Research. 2002;56(2):211-227.
  12

• 182.

  2002

  Debomoy K. Lahiri; Martin R. Farlow; Nigel H. Greig; Kumar Sambamurti

  Current drug targets for Alzheimer's disease treatment

  Drug Development Research. 2002;56(3):267-281.
  85

• 183.

  2002

  J.T. Rogers; J.D. Randall; P.S. Eder; X. Huang; A.I. Bush; R.E. Tanzi; A. Venti; S.M. Payton; T. Giordano; et al.

  Alzheimer's disease drug discovery targeted to the APP mRNA 5′untranslated region

  Journal of Molecular Neuroscience. 2002;19(1-2):77-82.
  40

• 184.

  2002

  Tadanobu Utsuki; Mohammed Shoaib; Harold W. Holloway; Donald K. Ingram; William C. Wallace; Vahram Haroutunian; Kumar Sambamurti; Debomoy K. Lahiri; Nigel H. Greig

  Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat

  Journal of Alzheimer's Disease. 2002;4(5):405-415.
  34

• 185.

  2002

  Girish J Kotwal; Debomoy K Lahiri; Ramona Hicks

  Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease.

  Annals of the New York Academy of Sciences. 2002;973:317-322.
  8

• 186.

  2002

  Y.-W. Ge; D.K. Lahiri

  Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimer's disease

  Annals of the New York Academy of Sciences. 2002;973:463-467.
  42

• 187.

  2002

  D.K. Lahiri; G.M. Alley; Y.-W. Ge; Y. Du

  Functional characterization of the 5′-regulatory region of the murine apolipoprotein gene

  Annals of the New York Academy of Sciences. 2002;973:340-344.
  8

• 188.

  2002

  D.K. Lahiri; G.J. Kotwal; M.R. Farlow; A. Sima; W. Kupsky; F.H. Sarkar; K. Sambamurti

  The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease

  Annals of the New York Academy of Sciences. 2002;973:334-339.
  8

• 189.

  2002

  Nigel H. Greig; Debomoy K. Lahiri; Kumar Sambamurti

  Butyrylcholinesterase: An important new target in Alzheimer's disease therapy

  International Psychogeriatrics. 2002;14(SUPPL. 1):77-91.
  80

• 190.

  2002

  Xiaoxiang Zhu; Qian-sheng Yu; Roy G. Cutler; Carsten W. Culmsee; Harold W. Holloway; Debomoy K. Lahiri; Mark P. Mattson; Nigel H. Greig

  Novel p53 inactivators with neuroprotective action: Syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives

  Journal of Medicinal Chemistry. 2002;45(23):5090-5097.
  56

• 191.

  2002

  Jack T. Rogers; Jeffrey D. Randall; Catherine M. Cahill; Paul S. Eder; Xudong Huang; Hiromi Gunshin; Lorene Leiter; Jay McPhee; Satinder S. Sarang; Tada Utsuki; et al.

  An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript

  Journal of Biological Chemistry. 2002;277(47):45518-45528.
  230

• 192.

  2001

  D. Lahiri; Y.W. Ge; X. Chen; J.I. Nurnberger Jr.; M.R. Farlow; Y. Du

  Differential promoter activity of the mouse apolipoprotein (APOE) gene in primary neurons, astrocytoma and in PC12 cells

  American Journal of Medical Genetics - Neuropsychiatric Genetics. 2001;105(7):589-590.
  0

• 193.

  2001

  N.H. Greig; T. Utsuki; Q.-S. Yu; X. Zhu; H.W. Holloway; T. Perry; B. Lee; D.K. Ingram; D.K. Lahiri

  A new therapeutic target in Alzheimer's disease treatment: Attention to butyryloholinesterase

  Current Medical Research and Opinion. 2001;17(3):159-165.
  90

• 194.

  2001

  Karen T. Y. Shaw; Tadanobu Utsuki; Jack Rogers; Qian-Sheng Yu; Kumar Sambamurti; Arnold Brossi; Yuan-Wen Ge; Debomoy K. Lahiri; Nigel H. Greig

  Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development

  Proceedings of the National Academy of Sciences of the United States of America. 2001;98(13):7605-7610.
  122

• 195.

  2000

  Chandramallika Ghosh; Weihong Song; Debomoy K. Lahiri

  Efficient DNA transfection in neuronal and astrocytic cell lines

  Molecular Biology Reports. 2000;27(2):113-121.
  16

• 196.

  2000

  Debomoy K. Lahiri; Yuan-Wen Ge

  Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue

  Brain Research Protocols. 2000;5(3):257-265.
  55

• 197.

  2000

  D.K. Lahiri; Y.-W. Ge; M.R. Farlow

  Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin

  Annals of the New York Academy of Sciences. 2000;903:387-393.
  15

• 198.

  2000

  John I. Nurnberger; Sherril Adkins; Debomoy K. Lahiri; Aimee Mayeda; Kuolung Hu; Alfred Lewy; Aaron Miller; Elizabeth S. Bowman; Marvin J. Miller; Leela N. Rau; et al.

  Melatonin suppression by light in euthymic bipolar and unipolar patients

  Archives of General Psychiatry. 2000;57(6):572-579.
  76

• 199.

  2000

  D.K. Lahiri; M.R. Farlow; N. Hintz; T. Utsuki; N.H. Greig

  Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease

  Acta Neurologica Scandinavica, Supplement. 2000;102(176):60-67.
  67

• 200.

  2000

  N.H. Greig; E. De Micheli; H.W. Holloway; Q.-S. Yu; T. Utsuki; T.A. Perry; D.K. Ingram; J. Deutsch; D. Lahiri; T.T. Soncrant

  The experimental alzheimer drug phenserine: Preclinical pharmacokinetics and pharmacodynamics

  Acta Neurologica Scandinavica, Supplement. 2000;102(176):74-84.
  38

• 201.

  2000

  Debomoy K. Lahiri; Weihong Song; Yuan-Wen Ge

  Analysis of the 5'-flanking region of the β-amyloid precursor protein gene that contributes to increased promoter activity in differentiated neuronal cells

  Molecular Brain Research. 2000;77(2):185-198.
  17

• 202.

  2000

  D.K. Lahiri; A. Zhang; K. Hu; J.I. Nurnberger Jr.

  Human G(olf) protein in cell lines derived from control and bipolar subjects

  American Journal of Medical Genetics - Neuropsychiatric Genetics. 2000;96(4):565.
  0

• 203.

  1999

  Debomoy K. Lahiri; Dawn Davis; John I. Nurnberger Jr.

  Detection of specific protein bands with melatonin-like immunoreactivity in different cell lines and human brain regions

  IUBMB Life. 1999;48(1):127-132.
  3

• 204.

  1999

  Martin R. Farlow; P.A. Cyrus; A. Nadel; D.K. Lahiri; A. Brashear; B. Gulanski

  Metrifonate treatment of AD influence of APOE genotype

  Neurology. 1999;53(9):2010-2016.
  43

• 205.

  1999

  Debomoy K. Lahiri

  Melatonin affects the metabolism of the β-amyloid precursor protein in different cell types

  Journal of Pineal Research. 1999;26(3):137-146.
  28

• 206.

  1999

  Debomoy K. Lahiri; Christina Nall; Yuan-Wen Ge

  Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element

  Molecular Brain Research. 1999;71(1):32-41.
  20

• 207.

  1999

  James Daly; Debomoy K. Lahiri; Girish J. Kotwal

  Examination of the interactions of the amyloid precursor protein carboxyl terminus to intracellular protein: Possible role in apoptosis

  Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1999;23(5):861-875.
  4

• 208.

  1999

  Chandramallika Ghosh; Debomoy K. Lahiri

  Increased vulnerability of neuronal cell lines to sodium nitroprusside- mediated toxicity is caused by the decreased level of nitric oxide metabolites

  Journal of Molecular Neuroscience. 1999;13(1-2):77-92.
  14

• 209.

  1999

  D.K. Lahiri; C. Ghosh

  Interactions between melatonin, reactive oxygen species, and nitric oxide

  Annals of the New York Academy of Sciences. 1999;893:325-330.
  18

• 210.

  1999

  D.K. Lahiri; Y. Xu; J. Klaunig; O. Baiyewu; A. Ogunniyi; K. Hall; H. Hendrie; A. Sahota

  Effect of oxidative stress on DNA damage and β-amyloid precursor proteins in lymphoblastoid cell lines from a Nigerian population

  Annals of the New York Academy of Sciences. 1999;893:331-336.
  11

• 211.

  1998

  Weihong Song; Debomoy K. Lahiri

  Isolation of the genomic clone of the rhesus monkey beta-amyloid precursor protein

  Biochemistry and Molecular Biology International. 1998;46(4):755-764.
  3

• 212.

  1998

  Martin R. Farlow; D.K. Lahiri; J. Poirier; J. Davignon; L. Schneider; S.L. Hui

  Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease

  Neurology. 1998;50(3):669-677.
  140

• 213.

  1998

  Weihong Song; Debomoy K. Lahiri

  Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein

  Gene. 1998;217(1-2):165-176.
  33

• 214.

  1998

  Weihong Song; Debomoy K. Lahiri

  Molecular cloning of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein: Structural characterization and a comparative study with other species

  Gene. 1998;217(1-2):151-164.
  28

• 215.

  1998

  Debomoy K. Lahiri

  An region upstream of the gene promoter for the β-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells

  Molecular Brain Research. 1998;58(1-2):112-122.
  25

• 216.

  1998

  Kumar Sambamurti; Debomoy K. Lahiri

  ERAB contains a putative noncleavable signal peptide

  Biochemical and Biophysical Research Communications. 1998;249(2):546-549.
  8

• 217.

  1998

  Debomoy K. Lahiri; Martin R. Farlow; Kumar Sambamurti

  The secretion of amyloid β-peptides is inhibited in the tacrine- treated human neuroblastoma cells

  Molecular Brain Research. 1998;62(2):131-140.
  58

• 218.

  1998

  J.I. Nurnberger Jr.; J. Trofatter; A. Mayeda; B. Tarricone; J. Hofstetter; J. Simon; N. Grahame; D.K. Lahiri; J. Belknap; J. Hingtgen

  Quantitative trait loci for traits related to affective disorder in inbred strains of mice

  American Journal of Medical Genetics - Neuropsychiatric Genetics. 1998;81(6):472.
  1

• 219.

  1998

  D.K. Lahiri; A. Zhang; J.I. Nurnberger Jr.

  Effect of lithium treatment on the Gα-OLF protein in transformed lymphoblastoid cell lines derived from unaffected and bipolar affective disorder subjects

  American Journal of Medical Genetics - Neuropsychiatric Genetics. 1998;81(6):478.
  0

• 220.

  1998

  James Daly IV; Debomoy K. Lahiri; David E. Justus; Girish J. Kotwal

  Detection of the membrane-retained carboxy-terminal tail containing polypeptides of the amyloid precursor protein in tissue from Alzheimer's disease brain

  Life Sciences. 1998;63(23):2121-2131.
  8

• 221.

  1997

  Sevilla D. Detera-Wadleigh; Judith A. Badner; Takeo Yoshikawa; Alan R. Sanders; Lynn R. Goldin; Gordon Turner; Denise Y. Rolling; Tracy Moses; Juliet J. Guroff; Diane Kazuba; et al.

  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 4, 7, 9, 18, 19, 20, and 21q

  American Journal of Medical Genetics - Neuropsychiatric Genetics. 1997;74(3):254-262.
  107

• 222.

  1997

  D.K. Lahiri

  An upstream regulatory element of human kapp gkne promoter binds a distinct protkin

  FASEB Journal. 1997;11(9):A972.
  0

• 223.

  1997

  D.K. Lahiri; M.R. Farlow; J.I. Nurnberger Jr.; N.H. Greig

  Effects of cholinesterase inhibitors on secretion of beta-amyloid precursor protein in cell cultures

  Annals of the New York Academy of Sciences. 1997;826:416-421.
  31

• 224.

  1997

  D.K. Lahiri; M.R. Farlow; K. Sambamurti; C. Nall

  The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells

  Life Sciences. 1997;61(20):1985-1992.
  8

• 225.

  1997

  Debomoy K. Lahiri; Aiwu Zhang; John I. Nurnberger Jr.

  High-resolution detection of PCR products from a microsatellite marker using a nonradioisotopic technique

  Biochemical and Molecular Medicine. 1997;60(1):70-75.
  16

• 226.

  1997

  Weihong Song; Debomoy K. Lahiri

  Melatonin Alters the Metabolism of the β-Amyloid Precursor Protein in the Neuroendocrine Cell Line PC12

  Journal of Molecular Neuroscience. 1997;9(2):75-92.
  44

• 227.

  1997

  John R. Hofstetter; Aiwu Zhang; Aimee R. Mayeda; Tim Guscar; John I. Nurnberger Jr.; Debomoy K. Lahiri

  Genomic DNA from mice: A comparison of recovery methods and tissue sources

  Biochemical and Molecular Medicine. 1997;62(2):197-202.
  25

• 228.

  1996

  Debomoy K. Lahiri; Martin R. Farlow

  Differential effect of tacrine and physostigmine on the secretion of the β-amyloid precursor protein in cell lines

  Journal of Molecular Neuroscience. 1996;7(1):41-49.
  37

• 229.

  1996

  Martin R. Farlow; Debomoy K. Lahiri; Judes Poirier; Jean Davignon; Siu Hui

  Apolipoprotein E genotype and gender influence response to tacrine therapy

  Annals of the New York Academy of Sciences. 1996;802:101-110.
  60

• 230.

  1995

  C.S. Von Koch; D.K. Lahiri; A.L. Mammen; N.G. Copeland; D.J. Gilbert; N.A. Jenkins; S.S. Sisodia

  The mouse APLP2 gene. Chromosomal localization and promoter characterization

  Journal of Biological Chemistry. 1995;270(43):25475-25480.
  15

• 231.

  1995

  H.C. Hendrie; K.S. Hall; S. Hui; F.W. Unverzagt; C.E. Yu; D.K. Lahiri; A. Sahota; M. Farlow; B. Musick; et al.

  Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans

  Annals of Neurology. 1995;37(1):118-120.
  95

• 232.

  1995

  W. Song; D.K. Lahiri

  Efficient transfection of DNA by mixing cells in suspension with calcium phosphate

  Nucleic Acids Research. 1995;23(17):3609-3611.
  23

• 233.

  1995

  Debomoy K. Lahiri; Christina Nall

  Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1

  Molecular Brain Research. 1995;32(2):233-240.
  84

• 234.

  1995

  D.K. Lahiri

  Molecular analysis of the promoter region of the gene encoding the beta-amyloid precursor protein.

  Indian journal of biochemistry & biophysics. 1995;32(6):329-335.
  3

• 235.

  1995

  Judes Poirier; Marie-Claude Delisle; Rémi Quirion; Isabelle Aubert; Martin Farlow; Debmoi Lahiri; Siu Hui; Philippe Bertrand; Josephine Nalbantoglu; Brian M. Gilfix; et al.

  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

  Proceedings of the National Academy of Sciences of the United States of America. 1995;92(26):12260-12264.
  435

• 236.

  1994

  Debomoy K. Lahiri

  Reversibility of the effect of tacrine on the secretion of the β-amyloid precursor protein in cultured cells

  Neuroscience Letters. 1994;181(1-2):149-152.
  18

• 237.

  1994

  D.K. Lahiri; S. Lewis; M.R. Farlow

  Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines

  Journal of Neuroscience Research. 1994;37(6):777-787.
  94

• 238.

  1994

  D.K. Lahiri; D. Davis; J.I. Nurnberger Jr.

  Melatonin-like immunoreactivity in the presence of different chemicals as determined by the radioimmunoassay

  Biochemical Medicine and Metabolic Biology. 1994;51(1):51-54.
  9

• 239.

  1994

  D.K. Lahiri

  Effect of ionophores on the processing of the β-amyloid precursor protein in different cell lines

  Cellular and Molecular Neurobiology. 1994;14(4):297-313.
  11

• 240.

  1993

  D.K. Lahiri; D. Davis; M. Adkins; J.I. Nurnberger Jr.

  Factors that influence radioimmunoassay of human plasma melatonin: A modified column procedure to eliminate interference

  Biochemical Medicine and Metabolic Biology. 1993;49(1):36-50.
  16

• 241.

  1993

  D.K. Lahiri

  The stability of β-amyloid precursor protein in nine different cell types

  Biochemistry and Molecular Biology International. 1993;29(5):849-858.
  4

• 242.

  1993

  Debomoy K. Lahiri; Bill Schnabel

  DNA isolation by a rapid method from human blood samples: Effects of MgCl₂, EDTA, storage time, and temperature on DNA yield and quality

  Biochemical Genetics. 1993;31(7-8):321-328.
  109

• 243.

  1992

  D.K. Lahiri; S. Bye; J.I. Nurnberger Jr.; M.E. Hodes; M. Crisp

  A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested

  Journal of Biochemical and Biophysical Methods. 1992;25(4):193-205.
  136

• 244.

  1992

  D.K. Lahiri; C. Nall; M.R. Farlow

  The cholinergic agonist carbachol reduces intracellular β-amyloid precursor protein in PC 12 and C6 cells

  Biochemistry International. 1992;28(5):853-860.
  9

• 245.

  1991

  D.K. Lahiri; N.K. Robakis

  The promoter activity of the gene encoding Alzheimer β-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences

  Molecular Brain Research. 1991;9(3):253-257.
  57

• 246.

  1991

  D.K. Lahiri; J.L. Nurnberger Jr

  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

  Nucleic Acids Research. 1991;19(19):5444.
  1156

• 247.

  1989

  G. La Fauci; D.K. Lahiri; S.R.J. Salton; N.K. Robakis

  Characterization of the 5'-end region and the first two exons of the β-protein precursor gene

  Biochemical and Biophysical Research Communications. 1989;159(1):297-304.
  33

• 248.

  1986

  Debomoy K. Lahiri; John O. Thomas

  A cDNA clone of the hnRNP C proteins and its homology with the single-stranded DNA binding protein UP2

  Nucleic Acids Research. 1986;14(10):4077-4094.
  10

• 249.

  1985

  D.K. Lahiri; J.O. Thomas

  The fate of heterogeneous nuclear ribonucleoprotein complexes during mitosis

  Journal of Biological Chemistry. 1985;260(1):598-603.
  3

• 250.

  1981

  A. Rai; D.K. Lahiri

  Subtyping of foot-and-mouth disease virus by the micro-enzyme-labelled immunosorbent assay (MICROELISA)

  Acta Virologica. 1981;25(1):53-56.
  0

• 251.

  1981

  A. Rai; D.K. Lahiri

  A micro-enzyme-labelled immunosorbent assay (MICROELISA) for the detection of foot-and-mouth disease virus antigen and antibody

  Acta Virologica. 1981;25(1):49-52.
  1

• 252.

  1980

  D.K. Lahiri; D.P. Burma

  Presence of precursor ribosome in the ribosomal preparation from chloramphenicol-treated Escherichia coli AB301/I05 (RNase III-)

  Journal of Biosciences. 1980;2(4):379-386.
  0

• 253.

  1980

  D.K. Lahiri; D.P. Burma

  Immunoprecipitation of 70S, 50S and 30S ribosomes of Escherichia coli

  Journal of Biosciences. 1980;2(1):55-61.
  0